口服氨甲环酸作为镰状细胞病患者持续性血尿的一种新的治疗选择。 - Suppr | 超能文献

Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.

作者信息

Davis Niall F, McGuire Barry B, Lawlor Leo, O'Gorman Peter, O'Malley Kiaran J, Fitzpatrick John M

出版信息

Ann Hematol. 2010 Nov;89(11):1179-80. doi: 10.1007/s00277-010-0936-y. Epub 2010 Apr 1.

DOI:10.1007/s00277-010-0936-y

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.口服氨甲环酸作为镰状细胞病患者持续性血尿的一种新的治疗选择。

Ann Hematol. 2010 Nov;89(11):1179-80. doi: 10.1007/s00277-010-0936-y. Epub 2010 Apr 1.

2

A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid.

Blood Coagul Fibrinolysis. 2006 Oct;17(7):589-91. doi: 10.1097/01.mbc.0000245293.41774.c8.

3

Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.全面评估新型口服氨甲环酸治疗月经过多的心脏 QTc 间期传导。

Expert Opin Pharmacother. 2010 Oct;11(14):2281-90. doi: 10.1517/14656566.2010.508071.

4

A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser.一项口服氨甲环酸预防 Q 开关红宝石激光后炎症后色素沉着过度的前瞻性随机对照研究。

Dermatol Surg. 2011 May;37(5):605-10. doi: 10.1111/j.1524-4725.2011.01957.x. Epub 2011 Apr 1.

5

Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria.遗传性多囊肾病患者伴严重血尿采用氨甲环酸的医学治疗。

Nefrologia. 2012;32(2):160-5. doi: 10.3265/Nefrologia.pre2011.Dec.11210. Epub 2012 Feb 4.

6

Tranexamic acid (Lysteda) for treatment of menorrhagia.氨甲环酸（Lysteda）用于治疗月经过多。

Med Lett Drugs Ther. 2010 Jul 12;52(1342):54-5.

7

Use of oral therapy for the prevention of postinflammatory hyperpigmentation.口服疗法用于预防炎症后色素沉着。

Dermatol Surg. 2011 May;37(5):611. doi: 10.1111/j.1524-4725.2011.01958.x.

8

Treatment of idiopathic menorrhagia with tranexamic acid.氨甲环酸治疗特发性月经过多

J Med Assoc Thai. 2005 Oct;88 Suppl 2:S1-6.

9

Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases.局部应用氨甲环酸控制凝血功能障碍妇科患者围手术期局部出血：两例报告

Haemophilia. 2007 Jan;13(1):115-6. doi: 10.1111/j.1365-2516.2006.01386.x.

10

[Recurrent macroscopic hematuria and heterozygote drepanocytosis].

Ann Med Interne (Paris). 1987;138(1):52-5.

引用本文的文献

1

Tranexamic acid-induced ureteric clot obstruction in a patient with urothelial cell carcinoma resulting in upper urinary tract perforation.氨甲环酸导致的输尿管血块梗阻，发生于一名患有尿路上皮癌的患者，导致上尿路穿孔。

BMJ Case Rep. 2022 Jan 17;15(1):e247334. doi: 10.1136/bcr-2021-247334.

2

Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises.氨甲环酸在一名患有镰状细胞病并接受后路脊柱侧弯矫正手术患者中的应用：安全减轻出血和血管闭塞性危机。

J Surg Case Rep. 2021 Jan 29;2021(1):rjaa559. doi: 10.1093/jscr/rjaa559. eCollection 2021 Jan.